Join
Live feed
·
INSIDERFilingvia Quantisnow
Marker Therapeutics Inc. logo

Director Elms Steve bought $35,472 worth of shares (11,085 units at $3.20) (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
MRKR· Marker Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MRKR (Marker Therapeutics Inc.) and more on Quantisnow.